**Core Concept:**
ADAMS 13 mutation refers to the genetic disorder Mutation in the gene for plasma protein Factor XIII (FXIII), a clotting factor. FXIII plays a crucial role in cross-linking fibrin molecules during the coagulation process, ensuring the stability and strength of blood clots. Factor XIII deficiency leads to impaired clot formation and increased bleeding tendency.

**Why the Correct Answer is Right:**
The correct answer, C. Ataxia Telangiectasia Mutated (ATM), is related to an unrelated condition, not ADAMS 13 mutation. ATM is associated with Ataxia Telangiectasia, a rare autosomal recessive disorder characterized by progressive cerebellar ataxia (loss of balance and coordination), ocular telangiectasia (abnormal dilation of blood vessels), and increased susceptibility to cancer and infections. ATM is a protein kinase involved in cellular response to DNA damage, cell cycle control, and apoptosis (programmed cell death). In contrast, ADAMS 13 mutation directly affects the coagulation process, leading to bleeding disorders.

**Why Each Wrong Option is Incorrect:**
A. **Mutation in FVIII (Factor VIII)**: This is related to Hemophilia A, a rare inherited bleeding disorder caused by deficiency or dysfunction of Factor VIII, an essential clotting factor involved in the intrinsic pathway of coagulation. Hemophilia A is not related to ADAMS 13 mutation.

B. **Mutation in FIX (Factor IX)**: This is associated with Hemophilia B, also known as Christmas disease, caused by deficiency or dysfunction of Factor IX, another clotting factor involved in the intrinsic pathway of coagulation. Hemophilia B is not related to ADAMS 13 mutation.

D. **Mutation in FXIII (Factor XIII)**: This is related to Factor XIII deficiency, a bleeding disorder resulting from reduced or absent FXIII activity. Factor XIII deficiency directly affects the coagulation process, similar to ADAMS 13 mutation, which is not the case for ADAMS 13 mutation.

**Clinical Pearl:**
ADAMS 13 mutation refers to a specific type of bleeding disorder caused by mutations in the F13A gene, which encodes for the A2 subunit of FXIII. These mutations lead to impaired FXIII activation and reduced FXIII activity, resulting in bleeding diathesis. The correct answer, C. ATM, is unrelated to the coagulation process but is involved in cellular response to DNA damage and apoptosis.